ASTH
Astrana Health, Inc. NASDAQ$35.19
Mkt Cap $2.0B
52w Low $18.08
96.3% of range
52w High $35.85
50d MA $26.93
200d MA $26.44
P/E (TTM)
75.8x
EV/EBITDA
15.0x
P/B
3.1x
Debt/Equity
1.4x
ROE
2.9%
P/FCF
11.7x
RSI (14)
—
ATR (14)
—
Beta
0.77
50d MA
$26.93
200d MA
$26.44
Avg Volume
512.4K
About
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model whic…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 0.15 | 0.54 | +260.0% | 26.32 | -1.9% | -6.9% | -2.8% | -4.7% | -5.4% | -6.1% | — |
| Nov 6, 2025 | AMC | 0.47 | 0.01 | -97.9% | 33.36 | -7.1% | -23.4% | -32.8% | -28.7% | -29.4% | -34.3% | — |
| Aug 7, 2025 | AMC | 0.36 | 0.19 | -47.2% | 21.46 | +11.8% | +30.8% | +33.7% | +35.6% | +38.1% | +37.7% | — |
| May 8, 2025 | AMC | 0.23 | 0.14 | -39.1% | 33.44 | -4.0% | -11.2% | -14.7% | -20.2% | -20.8% | -19.1% | — |
| Feb 27, 2025 | AMC | 0.22 | -0.15 | -168.2% | 34.68 | -10.0% | -26.8% | -23.6% | -22.8% | -21.6% | -21.5% | — |
| Nov 7, 2024 | AMC | 0.32 | 0.33 | +3.1% | 59.08 | -2.8% | -20.5% | -20.8% | -27.4% | -29.1% | -29.1% | — |
| Aug 7, 2024 | AMC | 0.39 | 0.40 | +2.6% | 46.36 | +11.8% | +1.1% | +3.3% | +0.8% | +2.9% | +0.5% | — |
| May 7, 2024 | AMC | 0.30 | 0.31 | +3.3% | 37.93 | -2.5% | +0.4% | +3.0% | +2.5% | +3.2% | +5.5% | — |
| Feb 27, 2024 | AMC | 0.15 | 0.26 | +73.3% | 43.54 | +1.9% | +0.5% | +3.4% | +0.1% | +1.0% | -0.7% | — |
| Nov 7, 2023 | AMC | 0.27 | 0.47 | +74.1% | 29.39 | +7.2% | +9.1% | +3.6% | +2.8% | +6.7% | +16.1% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $29.07 | $29.45 | +1.3% | +0.6% | +5.3% | +8.4% | +8.2% | +12.0% |
| Mar 13 | Truist | Maintains | Buy → Buy | — | $23.25 | $23.91 | +2.8% | +4.3% | +5.8% | +6.7% | +5.3% | +4.0% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $22.74 | $22.41 | -1.5% | -1.8% | -6.4% | -3.1% | -4.5% | -7.2% |
| Nov 25 | Jefferies | Maintains | Buy → Buy | — | $22.60 | $22.84 | +1.1% | +2.7% | +2.0% | +1.9% | +2.6% | +1.0% |
| Nov 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.50 | $21.96 | -2.4% | +0.4% | +3.2% | +2.4% | +2.4% | +3.0% |
| Nov 10 | TD Cowen | Maintains | Buy → Buy | — | $25.54 | $25.55 | +0.0% | -12.2% | -6.8% | -7.8% | -14.2% | -15.7% |
| Nov 7 | BTIG | Maintains | Buy → Buy | — | $33.36 | $31.00 | -7.1% | -23.4% | -32.8% | -28.7% | -29.4% | -34.3% |
| Mar 18 | Truist | Maintains | Buy → Buy | — | $30.60 | $30.29 | -1.0% | +4.7% | +3.0% | +0.7% | +0.9% | +4.2% |
| Mar 4 | BofA Securities | Maintains | Buy → Buy | — | $26.48 | $26.50 | +0.1% | +1.1% | +2.7% | +2.8% | +11.0% | +8.8% |
| Mar 3 | Baird | Maintains | Outperform → Outperform | — | $25.38 | $25.55 | +0.7% | +4.3% | +5.5% | +7.1% | +7.2% | +15.8% |
Recent Filings
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
ASTH completed a material acquisition, and investors should review the acquired business's financial performance in the filing to assess whether the deal enhances earnings and strategic positioning.
Mar 30
8-K · 7.01
! Medium
Astrana Health Inc. -- 8-K 7.01: Regulation FD Disclosure
Astrana Health disclosed corporate presentation slides via 8-K filing, though the company disclaims any obligation to update the information provided to investors.
Mar 4
NT 10-K
!!! Very High
Astrana Health Inc. -- Late Annual Report -- Distress Signal
Astrana Health's delayed annual report signals integration challenges from recent acquisitions may impact financial transparency and investor confidence in management's operational efficiency.
Mar 2
8-K · 8.01
!! High
Astrana Health Inc. -- 8-K 8.01: Material Event / Announcement
Astrana Health doubled its share repurchase authorization to $100 million, signaling management confidence and providing flexibility to return capital to shareholders through various purchase methods.
Mar 2
8-K · 5.02
!!! Very High
Black Hawk Acquisition Corporation Class A -- 8-K 5.02: Executive Change
Black Hawk Acquisition Corp appointed Mitchell Creem as CFO and Frederick Woodruff Field as director, strengthening management ahead of potential merger completion or operational transition.
Feb 3
Data updated apr 24, 2026 7:22pm
· Source: massive.com